13 See FIGURE 1 for a summary of current recommendations from the ADA for second-line therapy in patients with T2DM
The only good thing we can write about Ascorbyl Palmitate is that there is an in-vitro (made in the lab, not on real people) study showing that it might be able to boost collagen production
The SURPASS-J-combo trial embraced diabetic adults with HbA 1c 7% to 11% and BMI 23 kg/m 2 , stable weight and uncontrolled with therapy of metformin, thiazolidinedione, sulfonylureas, meglitinide, alpha-glucosidase inhibitor or SGLT2-i (81)
Compounding labs and gray-market sellers stepped in
Nobody finishes military boot camp, a dedicated year with a personal trainer, or a training block for a marathon, and reports back that nothing changed except their fitness metrics